Mylan enters MPP agreement over affordable hepatitis C generics

29-11-2016

Mylan enters MPP agreement over affordable hepatitis C generics

Photo courtesy of Mylan

Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool (MPP), a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries.


patent, hepatitis C, Medicines Patent Pool, Mylan, BMS, generics

LSIPR